StandardStandard

Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: 1 patients’ and physicians’ preferences for testing and service delivery. / Powell, G.; Holmes, E.A.; Plumpton, C.O. et al.
Yn: British Journal of Clinical Pharmacology, Cyfrol 80, Rhif 5, 03.07.2015, t. 1149-1159.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Powell, G, Holmes, EA, Plumpton, CO, Ring, A, Baker, GA, Jacoby, A, Pirmohamed, M, Marson, AG & Hughes, DA 2015, 'Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: 1 patients’ and physicians’ preferences for testing and service delivery', British Journal of Clinical Pharmacology, cyfrol. 80, rhif 5, tt. 1149-1159. https://doi.org/10.1111/bcp.12715

APA

CBE

MLA

VancouverVancouver

Powell G, Holmes EA, Plumpton CO, Ring A, Baker GA, Jacoby A et al. Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: 1 patients’ and physicians’ preferences for testing and service delivery. British Journal of Clinical Pharmacology. 2015 Gor 3;80(5):1149-1159. doi: 10.1111/bcp.12715

Author

RIS

TY - JOUR

T1 - Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: 1 patients’ and physicians’ preferences for testing and service delivery

AU - Powell, G.

AU - Holmes, E.A.

AU - Plumpton, C.O.

AU - Ring, A.

AU - Baker, G.A.

AU - Jacoby, A.

AU - Pirmohamed, M.

AU - Marson, A.G.

AU - Hughes, D.A.

PY - 2015/7/3

Y1 - 2015/7/3

U2 - 10.1111/bcp.12715

DO - 10.1111/bcp.12715

M3 - Article

VL - 80

SP - 1149

EP - 1159

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 5

ER -